Malignant clinical features of anaplastic gliomas without IDH mutation

BACKGROUND: Diagnosis of WHO grade III anaplastic gliomas does not always correspond to its clinical outcome because of the isocitrate dehydrogenase (IDH) gene status. Anaplastic gliomas without IDH mutation result in a poor prognosis, similar to grade IV glioblastomas. However, the malignant featur...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Shibahara, Ichiyo, Sonoda, Yukihiko, Shoji, Takuhiro, Kanamori, Masayuki, Saito, Ryuta, Inoue, Tomoo, Kawaguchi, Tomohiro, Yamashita, Yoji, Watanabe, Takashi, Kumabe, Toshihiro, Watanabe, Mika, Suzuki, Hiroyoshi, Tominaga, Teiji
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2015
主題:
Clinical Investigations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4483044/
https://ncbi.nlm.nih.gov/pubmed/24958096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou112
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料